Page 3 - Keystone Symposium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” Conference LEXINGTON, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer, will present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” conference this afternoon at 12:15 p.m. MST. The presentation will provide an update on progress with the Kaleido MMT TM platform, including a review of the K031 COVID-19 study interim dat...

Second Genome To Present Biomarker Data in Oncology at Keystone Symposium --Company Identifies Microbiome-based Composite Biomarker Predictive of Response to Immune Checkpoint Inhibitor-- News provided by Share this article Share this article SAN FRANCISCO, Jan. 19, 2021 /PRNewswire/ -- Second Genome, a leader in microbiome science, will present data today demonstrating the identification of a microbiome-based composite biomarker which can be used to predict response to immune checkpoint inhibitors. The data will be presented at the Keystone Symposium entitled "Harnessing the Microbiome for D...